Conditional survival after nephrectomy for renal cell carcinoma (RCC): changes in future survival probability over time

被引:31
作者
Bianchi, Marco [1 ,2 ]
Becker, Andreas [1 ,3 ]
Hansen, Jens [3 ]
Quoc-Dien Trinh [1 ,4 ]
Tian, Zhe [1 ]
Abdollah, Firas [2 ]
Briganti, Alberto [2 ]
Shariat, Shahrokh F. [5 ]
Perrotte, Paul [6 ]
Montorsi, Francesco [2 ]
Karakiewicz, Pierre I. [1 ,6 ]
Sun, Maxine [1 ]
机构
[1] Univ Montreal, Ctr Hlth, Canc Prognost & Hlth Outcomes Unit, Montreal, PQ H2X 3J4, Canada
[2] Univ Vita Salute San Raffaele, Dept Urol, Milan, Italy
[3] Prostate Canc Ctr Hamburg Eppendorf, Martini Clin, Hamburg, Germany
[4] Harvard Univ, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Surg,Div Urol,Med Sch, Boston, MA 02115 USA
[5] Cornell Univ, Weill Med Coll, Dept Urol, New York, NY 10021 USA
[6] Univ Montreal, Ctr Hlth, Dept Urol, Montreal, PQ H2X 3J4, Canada
关键词
renal cell carcinoma; RCC; conditional survival; nephrectomy; CANCER;
D O I
10.1111/bju.12115
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To examine the impact of length of survival on future survival probability, otherwise known as the effect of conditional survival (CS), after nephrectomy (NT) in patients diagnosed with renal cell carcinoma (RCC). Patients and Methods Overall, 42090 patients with RCC who underwent NT were abstracted from the Surveillance, Epidemiology, and End Results database (1988-2008). Based on cumulative survival estimates, CS rates were derived according to patient and disease characteristics. Separate multivariable Cox regression analyses were performed for the prediction of cancer-specific mortality (CSM), according to 1-, 2-, 3-, 4- and 5-year survival postoperatively. Results Immediately after surgery, the 5-year cancer-specific survival rate was 83.5%. Amongst patients who survived 1, 2, 3, 4, and 5 years after NT, the probability rates for surviving an additional 5 years were 87.0, 89.6, 90.9, 92.0 and 92.3%, respectively. Provided that patients survived 1 and 2 years after NT, the probability of being CSM-free for another 5 years increased by +4.1 and 4.3% for stage III and +12.9 and 10.3% for stage IV disease, respectively. Similar observations were recorded for patient age, grade, nodal stage and tumour size, and were confirmed upon multivariable analyses. Conclusion Survival probabilities vary according to length of survival after NT. Specifically, even amongst patients with more advanced disease at surgery, a more favourable prognosis can be achieved after surviving for 1-2 years.
引用
收藏
页码:E283 / E289
页数:7
相关论文
共 16 条
  • [1] Conditional Relative Survival of Cancer Patients and Conditional Probability of Death
    Bouvier, Anne-Marie
    Remontet, Laurent
    Hedelin, Guy
    Launoy, Guy
    Jooste, Valerie
    Grosclaude, Pascale
    Belot, Aurelien
    Lacour, Brigitte
    Esteve, Jacques
    Bossard, Nadine
    Faivre, Jean
    [J]. CANCER, 2009, 115 (19) : 4616 - 4624
  • [2] Conditional Survival Estimates Improve Over 5 Years for Melanoma Survivors with Node-Positive Disease
    Bowles, Tawnya L.
    Xing, Yan
    Hu, Chung-Yuan
    Mungovan, Kristi S.
    Askew, Robert L.
    Chang, George J.
    Gershenwald, Jeffrey E.
    Lee, Jeffrey E.
    Mansfield, Paul F.
    Ross, Merrick I.
    Cormier, Janice N.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (08) : 2015 - 2023
  • [3] Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma
    Capitanio, Umberto
    Jeldres, Claudio
    Patard, Jean-Jacques
    Perrotte, Paul
    Zini, Laurent
    de La Taille, Alexandre
    Ficarra, Vincenzo
    Cindolo, Luca
    Bensalah, Karim
    Artibani, Walter
    Tostain, Jacques
    Valeri, Antoine
    Zigeuner, Richard
    Mejean, Arnaud
    Descotes, Jean Luc
    Lechevallier, Eric
    Mulders, Peter F.
    Lang, Herve
    Jacqmin, Didier
    Karakiewicz, Pierre I.
    [J]. BJU INTERNATIONAL, 2009, 103 (01) : 33 - 37
  • [4] Howlader N., 2011, SEER cancer statistics review, 1975-2008
  • [5] Conditional Survival Predictions After Nephrectomy for Renal Cell Carcinoma
    Karakiewicz, Pierre I.
    Suardi, Nazareno
    Capitanio, Umberto
    Isbarn, Hendrik
    Jeldres, Claudio
    Perrotte, Paul
    Sun, Maxine
    Ficarra, Vincenzo
    Zigeuner, Richard
    Tostain, Jacques
    Mejean, Arnaud
    Cindolo, Luca
    Pantuck, Allan J.
    Belldegrun, Arie S.
    Zini, Laurent
    de la Taille, Alexandre
    Chautard, Denis
    Descotes, Jean-Luc
    Shariat, Shahrokh F.
    Valeri, Antoine
    Mulders, Peter F. A.
    Lang, Herve
    Lechevallier, Eric
    Patard, Jean-Jacques
    [J]. JOURNAL OF UROLOGY, 2009, 182 (06) : 2607 - 2612
  • [6] Clinical Calculator of Conditional Survival Estimates for Resected and Unresected Survivors of Pancreatic Cancer
    Katz, Matthew H. G.
    Hu, Chung-Yuan
    Fleming, Jason B.
    Pisters, Peter W. T.
    Lee, Jeffrey E.
    Chang, George J.
    [J]. ARCHIVES OF SURGERY, 2012, 147 (06) : 513 - 519
  • [7] Evaluating Overall Survival and Competing Risks of Death in Patients With Localized Renal Cell Carcinoma Using a Comprehensive Nomogram
    Kutikov, Alexander
    Egleston, Brian L.
    Wong, Yu-Ning
    Uzzo, Robert G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (02) : 311 - 317
  • [8] Conditional Probability of Survival in Patients With Newly Diagnosed Glioblastoma
    Polley, Mei-Yin C.
    Lamborn, Kathleen R.
    Chang, Susan M.
    Butowski, Nicholas
    Clarke, Jennifer L.
    Prados, Michael
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (31) : 4175 - 4180
  • [9] Node-positive renal cell carcinoma in the absence of distant metastases: predictors of cancer-specific mortality in a population-based cohort
    Quoc-Dien Trinh
    Schmitges, Jan
    Bianchi, Marco
    Sun, Maxine
    Shariat, Shahrokh F.
    Sammon, Jesse
    Jeldres, Claudio
    Zorn, Kevin
    Sukumar, Shyam
    Perrotte, Paul
    Graefen, Markus
    Rogers, Craig G.
    Peabody, James O.
    Menon, Mani
    Karakiewicz, Pierre I.
    [J]. BJU INTERNATIONAL, 2012, 110 (2B) : E21 - E27
  • [10] Cancer Statistics, 2012
    Siegel, Rebecca
    Naishadham, Deepa
    Jemal, Ahmedin
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2012, 62 (01) : 10 - 29